Trial Site Detail

 

Drug:
AT13387
Trial:
Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
Conditions: Solid Tumors
Trial Status:
Completed

 

Arizona Cancer Center

1515 North Campbell Avenue     
Tucson , AZ 85724-5024
USA

 

Principal Investigator:
Daruka Mahadevan, MD, PhD
Contact:
(520) 694-CURE(2873)
Activation Status of this Site:
Closed
Notes about this Site:
Arizona Cancer Center Website:
http://oncore.azcc.arizona.edu/sip/SIPControlServlet

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.